Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€117.40

€117.40

-0.930%
-1.1
-0.930%
€118.87

€118.87

 
12:58 / Tradegate WKN: A2PH5P / Symbol: TMDX / Name: Transmedics Group / Stock / ? /
Latest predictions
€121.29
01.05.24
6.10%
buy
€118.87
01.05.24
6.10%
buy
€112.31
01.05.24
6.10%
buy
€116.98
01.05.24
6.10%
buy
30.04.24
30.33%
buy
€130.00
29.04.24
32.00%
buy
Best running prediction
€65.42
07.11.23
106.51%
buy
Your prediction

Transmedics Group Inc Stock

The price for the Transmedics Group Inc stock decreased slightly today. Compared to yesterday there is a change of -€1.100 (-0.930%).
With 12 Buy predictions and not the single Sell prediction the community is currently very high on Transmedics Group Inc.
With a current price of 117.4 € Transmedics Group Inc is right around the predicted target price of 118 €.
So far the community has only identified positive things for Transmedics Group Inc stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Transmedics Group Inc in the next few years

Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) 6.10%
Target price 121.290
Change
Ends at 01.05.25

TransMedics Group, Inc. (NASDAQ: TMDX) had its price target raised by analysts at TD Cowen from $100.00 to $130.00. They now have a "buy" rating on the stock.
Ratings data for TMDX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 6.10%
Target price 118.872
Change
Ends at 01.05.25

TransMedics Group, Inc. (NASDAQ: TMDX) had its price target raised by analysts at JPMorgan Chase & Co. from $105.00 to $127.00. They now have an "overweight" rating on the stock.
Ratings data for TMDX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 6.10%
Target price 112.308
Change
Ends at 01.05.25

TransMedics Group, Inc. (NASDAQ: TMDX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $120.00 price target on the stock, up previously from $95.00.
Ratings data for TMDX provided by MarketBeat
Show more